Imicrit 500 mg/500 mg Injection
Marketer
Cipla Ltd
Salt Composition
Imipenem (500mg) + Cilastatin (500mg)
Overview Imicrit 500 mg/500 mg Injection
Combiflox 500 mg/500 mg Injection, a dual-antibiotic formulation, combats severe bacterial infections. Administered only by a healthcare provider, it targets infectious microorganisms to curb further spread. Consistent adherence to the prescribed dosage is crucial, completing the entire course regardless of symptom improvement. Typical side effects include nausea, vomiting, diarrhea, and skin rashes; injection site reactions like redness, swelling, and pain are also possible but usually transient. Severe or persistent side effects necessitate immediate medical attention. Allergic reactions (rashes, itching, swelling, breathing difficulties) demand urgent medical help. Prior to use, disclose all current medications to your physician, including those for pre-existing conditions. Pregnant or lactating individuals require medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if experiencing drowsiness or dizziness.
Uses of Imicrit 500 mg/500 mg Injection
Life-threatening bacterial infestations
Major Benefits of Imicrit 500 mg/500 mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Imicrit 500 mg/500 mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
How to use Imicrit 500 mg/500 mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Imicrit 500 mg/500 mg Injection works:
Imicrit 500 mg/500 mg Injection combines imipenem, a bacterial growth inhibitor, with cilastatin, a dehydropeptidase I inhibitor. Imipenem's antibiotic action disrupts the formation of crucial bacterial cell walls, hindering bacterial survival. Cilastatin safeguards imipenem from enzymatic degradation (by dehydropeptidase I), thus prolonging its therapeutic effect within the body.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Imicrit 500 mg/500 mg Injection may pose safety risks; therefore, physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
The use of Imicrit 500 mg/500 mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administration of Imicrit 500 mg/500 mg Injection during lactation appears to pose minimal risk. Available data from human studies indicate negligible danger to the infant.
DrivingUNSAFE
Imicrit 500 mg/500 mg Injection can induce adverse reactions potentially impairing driving capabilities. Certain side effects, including hallucinations (visual, auditory, or sensory), may impact a patient's ability to operate a vehicle.
KidneyCAUTION
The use of Imicrit 500 mg/500 mg Injection requires careful consideration in individuals with impaired kidney function. Dosage modification for Imicrit 500 mg/500 mg Injection might be necessary. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Imicrit 500 mg/500 mg Injection to individuals with hepatic impairment. Physician consultation is recommended.
What if you forget to take Imicrit 500 mg/500 mg Injection :
Should you forget a scheduled Imicrit 500 mg/500 mg Injection, seek your physician's advice.
Facts to Know About Imicrit 500 mg/500 mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobials |
3,018 People bought this recently